Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Neurology International|December 23, 2021
Multiple Sclerosis, Viruses, and New VaccinesPeter A C MapleVaccines|June 2, 2021
Population (Antibody) Testing for COVID-19-Technical Challenges, Application and Relevance, an English PerspectivePeter A C MapleVaccines|December 23, 2015
Application of Oral Fluid Assays in Support of Mumps, Rubella and Varicella Control ProgramsPeter A C MapleVaccines|January 24, 2020
Cytomegalovirus and Epstein-Barr Virus Associations with Neurological Diseases and the Need for Vaccine DevelopmentPeter A C MapleVaccines|February 28, 2023
COVID-19, SARS-CoV-2 Vaccination, and Human Herpesviruses InfectionsPeter A C MapleClinical Oncology (Royal College of Radiologists (Great Britain))|December 22, 2020
How Useful is COVID-19 Antibody Testing - A Current Assessment for OncologistsP A C Maple, K SikoraVaccines|June 27, 2025
Human Alpha Herpesviruses Infections (HSV1, HSV2, and VZV), Alzheimer's Disease, and the Potential Benefits of Targeted Treatment or Vaccination-A Virological PerspectivePeter A C Maple, Akram A HosseiniClinical and Vaccine Immunology : CVI|September 17, 2010
Characterization of Treponema pallidum particle agglutination assay-negative sera following screening by treponemal total antibody enzyme immunoassaysP A C Maple, D Ratcliffe, E SmitThe Journal of Infection|November 4, 2019
A different response to cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infection in UK people with multiple sclerosis (PwMS) compared to controlsPeter A C Maple, Radu Tanasescu, Bruno Gran, et al.Pageof 4